[en] BACKGROUND: Positron emission tomography (PET) has been shown useful for the staging of patients with various carcinomas. METHODS: We have applied this technique to 54 cases of colorectal carcinoma and compared it to conventional imaging techniques. RESULTS: PET had moderately higher sensitivity and specificity than conventional techniques to detect individual lesion sites (75% vs 70.8% and 63% vs 21% respectively). It detected the same number of patients with recurrences (35/39) but overestimated disease less frequently (5 cases vs 12). PET favorably influenced therapeutic management in 17 patients, indicating different or additional surgery in 9 while avoiding surgery with curative intent or unnecessary surgery in 8. In 5 cases, erroneous information provided by PET could be corrected by conventional imaging techniques. CONCLUSION: We conclude that PET appears to provide complementary information useful for staging patients with colorectal carcinomas. It can significantly modify patients management. These data should be confirmed by a prospective study.
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Hustinx, Roland ; Université de Liège - ULiège > Département des sciences cliniques > Médecine nucléaire
Paulus, P.
Daenen, Frédéric ; Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire
Detroz, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Honore, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
Comhair, Nicole ; Centre Hospitalier Universitaire de Liège - CHU > Administration des patients - Expédition
Rigo, Pierre ; Université de Liège - ULiège > Département des sciences de la motricité > Pathologie générale et médecine nucléaire
Language :
French
Title :
Interet clinique de la tomographie a emission de positons dans la detection et le bilan d'extension des recidives des cancers colorectaux
Alternative titles :
[en] Clinical Value of Positron Emission Tomography in the Detection and Staging of Recurrent Colorectal Cancer
Gore RM. Colorectal cancer. Clinical and pathologic features. Radiol Clin North Am 1997;35:403-29.
Mehta S, Johnson RJ, Schofield PF. Staging of colorectal cancer. Clin Radiol 1994;49:515-23.
Safi F, Link KH, Berger HG. Is follow-up of colorectal cancer patients worthwhile ? Dis Colon Rectum 1993;36:636-44.
Moertel CG, Fleming TRR, MacDonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943-7.
Vernava AM, Longo WE, Virgo KS, Coplin MA, Wade TP, Johnson FE. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994;37:573-83.
Steele G. Standard postoperative monitoring of patients after primary resection of colon and rectum cancer. Cancer 1993;71: 4225-35.
Kievit J, Bruinvels DJ. Detection of recurrence after surgery for colorectal cancer. Eur J Cancer 1995;31A : 1222-5.
Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 1995;273:1837-41.
Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23: 1641-74.
Wahl RL. Positron emission tomography : application in oncology. In : Murray ICP, EII PJ, eds. Nuclear Medicine, Clinical Diagnosis and Treatment. London : Churchill Livingstone. 1995, 801-20.
Conti PS, Lilien DL, Hawley K, Keppler J, Grafton ST, Bading JR. PET and 18F-FDG in oncology : a clinical update. Nucl Med Biol 1996;23:717-35.
Warburg O, Wind F, Neglers E. On the metabolism of tumors in the body. In : Warburg O, ed. Metabolism of tumors. London : Constable, 1930:254-70.
Schlag P, Lehner B, Strauss LG, Georgi P, Herfarth C. Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy. Arch Surg 1989;124:197-200.
Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R, et al. Recurrence of colorectal tumors : PET evaluation. Radiology 1989;170:329-32.
Vitola JV, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright JK, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171: 21-6.
Schiepers C, Penninckx F, De Vadder N, Merckx E, Mortelmans L, Bormans G, et al. Contribution of PET in the diagnosis of recurrent colorectal cancer : comparison with conventional imaging. Eur J Surg Oncol 1995;21:517-22.
Beets G, Penninckx F, Schiepers C, Mortelmans L, Kerremans R, Aerts R, et al. Clinical value of whole-body positron emission tomography with (18F)-fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 1994;81:1666-70.
Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, et al. Recurrent rectal cancer and scar : differentiation with PET and MR imaging. Radiology 1992;182:549-52.
Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK. Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 1996;23:737-43.
Lai DTM, Fulham M, Stephen MS, Chu KM, Solomon M, Thompson JF, et al. The role of whole-body positron emission tomography with 18F-fluorodeoxyglucose in identifying operable colorectal cancer metastases of the liver. Arch Surg 1996;131: 703-7.
Blend MJ, Abdel-Nabi H. New methods for the staging of colorectal cancer using noninvasive techniques. Semin Surg Oncol 1996;12:253-63.
Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196-201.
Beckers C, Paulus P, Rigo P. Evaluation abdomino-pelvienne des cancers ovariens : comparaison de la lomographie à émission de positons au 18-FDG avec la laparotomie exploratrice. Med Nucl Imag Fonct Metab 1996;20:479.
Higashi K, Seki H, Taniguchi M, et al. Bronchioloalveolar carcinoma : false-negative results on FDG-PET (abstract). J Nucl Med 1997;38 (Suppl.) : 79P.
Kinkel K, Tardivon AA, Soyer P, Spatz A, Lasser P, Rougier P, et al. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm : a prospective study of 41 patients. Radiology 1996;200:453-8.
Karp JS, Muehllehner G, Qu H, Yan XH. Singles transmission in volume-imaging PET with a 137 Cs source. Phys Med Biol 1995;40:929-44.
Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning : potential for error in interpretation. Semin Nucl Med 1996;26:308-14.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
